Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.430
+0.010 (0.70%)
At close: Oct 29, 2026, 4:00 PM EDT
1.400
-0.030 (-2.10%)
Pre-market: Oct 30, 2026, 4:00 AM EDT
ZYBT Revenue
In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M CNY, down -37.56%. Zhengye Biotechnology Holding had revenue of 54.03M in the half year ending December 31, 2025, a decrease of -43.00%. That makes Zhengye Biotechnology Holding the 34,826th largest company in the world by revenue and 4,586th in the United States.
Revenue (ttm)
116.36M CNY
Revenue Growth
-37.56%
P/S Ratio
4.07
Revenue / Employee
432,572 CNY
Employees
269
Market Cap
67.77M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 116.36M | -69.99M | -37.56% |
| Dec 31, 2024 | 186.36M | -25.30M | -11.95% |
| Dec 31, 2023 | 211.65M | -48.62M | -18.68% |
| Dec 31, 2022 | 260.27M | 46.20M | 21.58% |
| Dec 31, 2021 | 214.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Organogenesis Holdings | 457.45M |
| Organigram Global | 217.71M |
| InterCure | 84.76M |
| Journey Medical | 68.18M |
| BGM Group | 47.90M |
| Cumberland Pharmaceuticals | 44.30M |
| SCYNEXIS | 19.22M |
| Incannex Healthcare | 12.00K |
ZYBT News
- 2 months ago - Zhengye Biotechnology regains compliance with Nasdaq - TheFly
- 2 months ago - Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement - GlobeNewsWire
- 3 months ago - Zhengye Biotechnology Holding Ltd trading resumes - TheFly
- 3 months ago - Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause - TheFly
- 3 months ago - Zhengye Biotechnology issues statement in response to unusual trading activity - TheFly
- 3 months ago - Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity - GlobeNewsWire
- 4 months ago - Zhengye Biotechnology receives deficiency notice over minimum bid price - TheFly
- 4 months ago - Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire